Neurometa Therapeutics ApS
Private limited companyCVR 44557703Aalborg ØstActive
Neurometa Therapeutics ApS is a private limited company, based in Aalborg Øst, active in research and experimental development on natural sciences and engineering, founded in 2024. Equity was negative at the end of 2025 (−DKK 264k). The company made a loss in both 2024 and 2025, most recently DKK 18,563. The company is new and has been registered for 2 years.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss got smaller: from DKK 286k to DKK 18,563 (2024 → 2025).
- Equity turned negative: −DKK 264k (2024 → 2025).
Management and owners, last 24 months
- Stepped down: Anne Skøttrup Mørkholt (director, 29/09/2026).
- New owners registered: Neurometa Therapeutics AB (29/09/2026).
- No longer registered as owner: Helgudottir Holding ApS (29/09/2026), AKGM Holding ApS (29/09/2026) and J&P Pharma Holding AB (29/09/2026).
Registrations, last 24 months
- 29/09/2026: Name changed from Geysir Therapeutics ApS to Neurometa Therapeutics ApS
- 06/05/2026: Moved to Kaolinvej 5, 9220 Aalborg Øst
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2024–2025 · amounts in DKK thousandEquity and net profit
| 2024 | 2025 | Change | |
|---|---|---|---|
| Revenue | not stated | not stated | – |
| Gross profit | −32 | −17 | +45.5% |
| Operating profit (EBIT) | −285 | −19 | +93.5% |
| Net profit | −286 | −19 | +93.5% |
| Total assets | 77 | 57 | −25.5% |
| Equity | 61 | −264 | −534.2% |
| Liabilities | 16 | 322 | +1,906.6% |
| Cash and cash equivalents | 75 | 57 | −24.1% |
| Average number of employees | – | 0 | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresNegative equity
Equity was −DKK 264k at the end of 2025.
How is this calculated?
Equity in the latest annual report is below zero.
Loss for 2 years in a row
Net result has been negative in 2024–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
2 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 06/07/2026 | The company | PDF not statedXBRL |
| 2024 | 02/01/2024 – 31/12/2024 | 01/07/2025 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Position in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 63,956of 69,742 Better than 8% | No. 64,276of 69,964 Better than 8% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 182of 323 Better than 44% | No. 234of 329 Better than 29% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 15,298of 16,614 Better than 8% | No. 14,815of 16,661 Better than 11% |
| All companies of type ApS66,508 companies in the comparison | No. 61,484of 66,379 Better than 7% | No. 60,675of 66,505 Better than 9% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Neurometa Therapeutics ApS−DKK 17,476
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Neurometa Therapeutics ApS−DKK 18,563
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Neurometa Therapeutics ApS−DKK 264k
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Neurometa Therapeutics ApS2
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Neurometa Therapeutics AB100%
Management
3 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Preben Bruun-Nyzell | Director | 02/01/2024 |
| Josephus Dirk Vestergaard Nieland | Director | 02/01/2024 |
| Steinunn Sara Helgudóttir | Director | 02/01/2024 |
- Founders
- Helgudottir Holding ApS, AKGM Holding ApS, J&P Pharma Holding AB
Former management (1)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Anne Skøttrup Mørkholt | Director | 02/01/2024 | 29/09/2026 |
Signing rule: Selskabet tegnes af direktionen i forening.
Address and production units
1 active production unitsKaolinvej 5
9220 Aalborg Øst
Aalborg Municipality · Postcode 9220
Other companies at the address (2)
- Malerfirmaet Bent Pedersen A/SPainting
- 2A Pharma ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Neurometa Therapeutics ApS | Kaolinvej 5, 9220 Aalborg Øst | 2 | 1029996012 |
Purpose
Selskabets formål er at drive virksomhed med forskning, udvikling, kommercialisering, handel og fabrikation af lægemidler og dermed beslægtet virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
18 registered events20268 changesname 1 · management 1 · ownership 4 · accounts 1 · address 1
- NameName changed from Geysir Therapeutics ApS to Neurometa Therapeutics ApS
- ManagementAnne Skøttrup Mørkholt stepped down as director
- OwnershipNeurometa Therapeutics AB registered as owner (100%)
- OwnershipHelgudottir Holding ApS is no longer registered as owner
- OwnershipAKGM Holding ApS is no longer registered as owner
- OwnershipJ&P Pharma Holding AB is no longer registered as owner
- AccountsAnnual report for 2025 published
- AddressMoved to Kaolinvej 5, 9220 Aalborg Øst
20252 changesaccounts 1 · industry 1
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20248 changesfounded 1 · management 4 · ownership 3
- FoundedRegistered as Geysir Therapeutics ApS
- ManagementAnne Skøttrup Mørkholt appointed director
- ManagementPreben Bruun-Nyzell appointed director
- ManagementJosephus Dirk Vestergaard Nieland appointed director
- ManagementSteinunn Sara Helgudóttir appointed director
- OwnershipHelgudottir Holding ApS registered as owner (20%)
- OwnershipAKGM Holding ApS registered as owner (20%)
- OwnershipJ&P Pharma Holding AB registered as owner (33.33%)
Related companies
Same industry in Aalborg
- MyDefence A/S115 employees
- Rohde & Schwarz Technology Center A/S58 employees
- Nanonord A/S33 employees
- Dnasense ApS12 employees
- Steeper Energy Technologies ApS7 employees
- Biogenity ApS6 employees
Same people in management
- Malerfirmaet Bent Pedersen A/Svia Josephus Dirk Vestergaard Nieland
- 2A Pharma ApSvia Josephus Dirk Vestergaard Nieland
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.